John T Curnutte Insider Trading $PTLA PORTOLA PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John T Curnutte.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John T Curnutte. John T Curnutte is Director in Diadexus, Inc. ($DDXS) and EVP R&D in PORTOLA PHARMACEUTICALS INC ($PTLA) and Executive Vice President in PORTOLA PHARMACEUTICALS INC ($PTLA) and Interim Co-President & EVP R&D in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in Orchard Therapeutics plc ($ORTX).
John T Curnutte in PORTOLA PHARMACEUTICALS INC
Trading Symbol: PTLAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John T Curnutte: Interim Co-President & EVP R&D, Executive Vice President
Holdings: 103,227 shares
Current Value: $2,919,260
Latest Transaction: May 21 2019
$PTLA Market Capitalization: $1.55B
$PTLA Previous Close: $28.28
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John T Curnutte in PORTOLA PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DDXS, ORTX, PTLA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Option Exercise | M | 0.00 | 4,688 | 0 | 0 | |
May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Payment of Exercise | F | 28.69 | 903 | 25,907 | 101,656 | 102.6 K to 101.7 K (-0.88 %) |
May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Payment of Exercise | F | 28.69 | 2,418 | 69,372 | 102,559 | 105 K to 102.6 K (-2.30 %) |
May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 1,750 | 0 | 104,977 | 103.2 K to 105 K (+1.70 %) |
May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 4,688 | 0 | 103,227 | 98.5 K to 103.2 K (+4.76 %) |
Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Option Exercise | A | 27.10 | 18,000 | 487,800 | 18,000 | |
Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 4,500 | 0 | 104,985 | 100.5 K to 105 K (+4.48 %) |
Jan 15 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Payment of Exercise | F | 24.25 | 715 | 17,339 | 100,485 | 101.2 K to 100.5 K (-0.71 %) |
Jan 15 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 1,750 | 0 | 101,200 | 99.5 K to 101.2 K (+1.76 %) |
Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Interim Co-Presiden ... | Payment of Exercise | F | 29.18 | 8,884 | 259,203 | 101,200 | 110.1 K to 101.2 K (-8.07 %) |
Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Interim Co-Presiden ... | Buy | M | 0.00 | 17,500 | 0 | 110,084 | 92.6 K to 110.1 K (+18.90 %) |
Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Interim Co-Presiden ... | Payment of Exercise | F | 26.05 | 8,171 | 212,855 | 110,084 | 118.3 K to 110.1 K (-6.91 %) |
Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Interim Co-Presiden ... | Buy | M | 0.00 | 17,500 | 0 | 118,255 | 100.8 K to 118.3 K (+17.37 %) |
May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Payment of Exercise | F | 40.82 | 1,647 | 67,231 | 118,255 | 119.9 K to 118.3 K (-1.37 %) |
May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Grant | A | 0.00 | 4,687 | 0 | 119,902 | 115.2 K to 119.9 K (+4.07 %) |
Mar 14 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 5,049 | 42,917 | 0 | |
Mar 14 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 5,049 | 42,917 | 5,049 | 0 to 5 K |
Mar 06 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Payment of Exercise | F | 32.53 | 4,530 | 147,361 | 22,499 | 27 K to 22.5 K (-16.76 %) |
Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | A | 51.31 | 35,000 | 1,795,850 | 35,000 | |
Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Grant | A | 0.00 | 8,750 | 0 | 8,750 | 0 to 8.8 K |
Sep 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 7.00 | 14,285 | 99,995 | 0 | |
Sep 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 6,715 | 57,078 | 5,049 | |
Sep 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 7.00 | 14,285 | 99,995 | 14,285 | 0 to 14.3 K |
Sep 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 6,715 | 57,078 | 6,715 | 0 to 6.7 K |
Aug 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Payment of Exercise | F | 54.86 | 2,644 | 145,050 | 0 | 2.6 K to 0 (-100.00 %) |
Jul 20 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 10,000 | 85,000 | 1,918 | |
Jul 20 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 65.00 | 10,000 | 650,000 | 0 | 10 K to 0 (-100.00 %) |
Jul 20 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 10,000 | 85,000 | 10,000 | 0 to 10 K |
Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 60,000 | 510,000 | 11,918 | |
Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 60.00 | 10,000 | 600,000 | 0 | 10 K to 0 (-100.00 %) |
Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 59.33 | 3,802 | 225,573 | 10,000 | 13.8 K to 10 K (-27.55 %) |
Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 58.35 | 17,954 | 1,047,616 | 13,802 | 31.8 K to 13.8 K (-56.54 %) |
Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 57.24 | 10,729 | 614,128 | 31,756 | 42.5 K to 31.8 K (-25.25 %) |
Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 56.71 | 11,356 | 643,999 | 42,485 | 53.8 K to 42.5 K (-21.09 %) |
Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 55.47 | 6,159 | 341,640 | 53,841 | 60 K to 53.8 K (-10.26 %) |
Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 60,000 | 510,000 | 60,000 | 0 to 60 K |
Mar 03 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Payment of Exercise | F | 38.61 | 3,327 | 128,455 | 34,152 | 37.5 K to 34.2 K (-8.88 %) |
Feb 01 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
Feb 01 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | A | 25.54 | 50,000 | 1,277,000 | 50,000 | |
Feb 01 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
May 03 2016 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | A | 23.76 | 12,500 | 297,000 | 12,500 | |
May 03 2016 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Grant | A | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
Mar 04 2016 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Payment of Exercise | F | 31.75 | 1,271 | 40,354 | 8,729 | 10 K to 8.7 K (-12.71 %) |
Jan 29 2016 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jan 29 2016 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | A | 33.49 | 40,000 | 1,339,600 | 40,000 | |
Jan 29 2016 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jul 15 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 10,000 | 85,000 | 71,918 | |
Jul 15 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 50.00 | 10,000 | 500,000 | 0 | 10 K to 0 (-100.00 %) |
Jul 15 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 10,000 | 85,000 | 10,000 | 0 to 10 K |
Jun 22 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 10,000 | 85,000 | 81,918 | |
Jun 22 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 47.50 | 10,000 | 475,000 | 0 | 10 K to 0 (-100.00 %) |
Jun 22 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 10,000 | 85,000 | 10,000 | 0 to 10 K |
Jun 17 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 10,000 | 85,000 | 91,918 | |
Jun 17 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 45.00 | 10,000 | 450,000 | 0 | 10 K to 0 (-100.00 %) |
Jun 17 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 10,000 | 85,000 | 10,000 | 0 to 10 K |
May 29 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 10,000 | 85,000 | 113,682 | |
May 29 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 42.50 | 10,000 | 425,000 | 0 | 10 K to 0 (-100.00 %) |
May 29 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 10,000 | 85,000 | 10,000 | 0 to 10 K |
May 28 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 10,000 | 85,000 | 123,682 | |
May 28 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 41.18 | 1,000 | 41,180 | 0 | 1,000 to 0 (-100.00 %) |
May 28 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 40.20 | 9,000 | 361,800 | 1,000 | 10 K to 1,000 (-90.00 %) |
May 28 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 10,000 | 85,000 | 10,000 | 0 to 10 K |
Feb 23 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 10,000 | 85,000 | 133,682 | |
Feb 23 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 40.00 | 10,000 | 400,000 | 0 | 10 K to 0 (-100.00 %) |
Feb 23 2015 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 10,000 | 85,000 | 10,000 | 0 to 10 K |
Mar 27 2014 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | A | 25.08 | 75,000 | 1,881,000 | 75,000 |
Page: 1